Uvere Ezinne O, Akinyemi Joshua, Sarfo Fred S, Fakunle Adekunle, Okekunle Akinkunmi Paul, Akpa Onoja, Akpalu Albert, Wahab Kolawole, Obiako Reginald, Komolafe Morenikeji, Owolabi Lukman, Osaigbovo Godwin O, Ogbole Godwin, Tiwari Hemant K, Jenkins Carolyn, Olowookere Samuel, Arulogun Oyedunni, Akpalu Josephine, Asowata Osahon J, Ibinaiye Philip, Akisanya Cynthia, Oyinloye Olalekan I, Appiah Lambert, Agunloye Atinuke M, Adeoye Abiodun M, Yaria Joseph, Lackland Daniel T, Arnett Donna, Laryea Ruth Y, Calys-Tagoe Benedict, Ogah Okechukwu S, Ogunronbi Mayowa, Isah Suleiman Y, Dambatta Hamisu A, Tagge Raelle, Balogun Olayemi, Agbogu-Ike Obiageli U, Akinyemi Rufus, Ovbiagele Bruce, Owolabi Mayowa
Department of Medicine, University of Ibadan, Nigeria.
Department of Health Promotion and Education, University of Ibadan, Nigeria.
eNeurologicalSci. 2025 Jun 11;40:100573. doi: 10.1016/j.ensci.2025.100573. eCollection 2025 Sep.
Several factors have been independently associated with stroke occurrence globally. However, the association between sedative use and stroke risk is yet to be established in West Africa.
To assess the association between sedatives and stroke among West Africans.
Adults aged ≥18 years with confirmed stroke as well as age- and sex-matched controls were enrolled into the Stroke Investigative Research and Education Network (SIREN) study. Sedative use was determined by retrospective assessment on the use of any type of sedative in the preceding year while stroke was confirmed with brain scan and clinical features. Univariate and multivariate analyses, using logistic regressions, were performed to establish associations between sedative use and stroke while adjusting for other stroke risk factors.
A total of 7104 subjects (3553 stroke cases and 3551 stroke-free controls participated in this study. The mean age was 60.9 ± 0.78 among cases and 59.8 ± 11.44 years among controls ( < 0.029). History of sedative use was more common in cases (7.7 %) compared to controls (4.3 %; < 0.001) After adjusting for age, income >$100, history of hypertension, diabetes, dyslipidaemia, tobacco & alcohol use, physical inactivity, green leafy vegetable and meat consumption, sedative use was independently associated with stroke risk (aOR: 1.41; 95 %CI: 1.01-1.96; < 0.041). Sedative use was associated with higher odds of stroke among adults aged ≥50 years (aOR: 1.53; 95 %CI: 1.28-2.04; < 0.019).
Sedative use was independently associated with stroke risk among adults in West Africa. Its use requires further exploration and prospective study to address the emerging association with stroke occurrence.
全球范围内,多种因素与中风的发生独立相关。然而,在西非,镇静剂的使用与中风风险之间的关联尚未确立。
评估西非人群中镇静剂与中风之间的关联。
年龄≥18岁的确诊中风患者以及年龄和性别匹配的对照组被纳入中风调查研究与教育网络(SIREN)研究。通过回顾性评估前一年任何类型镇静剂的使用情况来确定镇静剂的使用,同时通过脑部扫描和临床特征确诊中风。使用逻辑回归进行单因素和多因素分析,以确定镇静剂使用与中风之间的关联,同时调整其他中风风险因素。
共有7104名受试者(3553例中风病例和3551例无中风对照)参与了本研究。病例组的平均年龄为60.9±0.78岁,对照组为59.8±11.44岁(P<0.029)。与对照组(4.3%;P<0.001)相比,病例组中使用镇静剂的病史更为常见(7.7%)。在调整年龄、收入>100美元、高血压病史、糖尿病、血脂异常、烟草和酒精使用、身体活动不足、绿叶蔬菜和肉类消费后,镇静剂的使用与中风风险独立相关(调整后比值比:1.41;95%置信区间:1.01-1.96;P<0.041)。在年龄≥50岁的成年人中,使用镇静剂与中风几率较高相关(调整后比值比:1.53;95%置信区间:1.28-2.04;P<0.019)。
在西非成年人中,镇静剂的使用与中风风险独立相关。其使用需要进一步探索和前瞻性研究,以解决与中风发生的新出现的关联。